Početna › T-stanični limfom › Minnesota
Kliničke studije za T-stanični limfom u državi Minnesota
9 studija za T-stanični limfom traži sudionike na lokacijama u državi Minnesota.
Gradovi u državi Minnesota
Službeni tekst studije (engleski)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Essentia Health Cancer Center, Duluth
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04803201Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06724237Allo HSCT Using RIC and PTCy for Hematological Diseases
- Masonic Cancer Center at University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Do 75 godina · Oba spola · Ažurirano 6. srp 2026. · NCT05805605Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT06508463A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. lip 2026. · NCT03017820A Registry for People With T-cell Lymphoma
- Mayo Clinic (Data Collection Only), Rochester
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 20. svi 2026. · NCT05978141Auto Stem Cell Transplant for Lymphoma Patients
- Masonic Cancer Center, University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Do 75 godina · Oba spola · Ažurirano 4. stu 2025. · NCT03125642Q702 for the Treatment of Patients With Hematologic Malignancies
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. lis 2025. · NCT06712810Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital and Clinics of Minnesota, Minneapolis
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.